AVCTF:OTC-Avacta Group Plc (USD)

COMMON STOCK | Medical Devices | OTC

Last Closing Price

USD 3.50

Change

0.00 (0.00)%

Market Cap

N/A

Volume

100.00

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-05 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SNNUF Smith & Nephew plc

+0.77 (+3.58%)

USD19.07B 41.99 23.99
MCRPF MicroPort Scientific Corporati..

N/A

USD13.15B 219.70 53.08
GGNDF GN Store Nord A/S

N/A

USD11.89B 58.49 4.40
GNNDY GN Store Nord A/S

+6.80 (+2.56%)

USD11.40B 56.82 4.40
CHEOF Cochlear Limited

N/A

USD11.24B 45.76 23.12
CHEOY Cochlear Limited

N/A

USD10.93B 51.97 23.12
MEDGF Medacta Group SA

+8.90 (+7.77%)

USD2.57B 51.41 33.62
NHNKY Nihon Kohden Corporation

N/A

USD2.43B 19.71 0.09
NHNKF Nihon Kohden Corporation

N/A

USD2.11B 24.60 -78.50
DWRKF Drägerwerk AG & Co. KGaA

N/A

USD1.93B 58.71 N/A

ETFs Containing AVCTF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 141.38% 77% C+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 141.38% 77% C+ 84% B
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.24 93% A 89% B+
Price / Cash Flow Ratio N/A N/A N/A N/A N/A
EV/EBITDA -4.60 96% A 92% A-
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.